Reliability and validity of the Turkish version of the somatic symptom disorder-B criteria scale (SSD-12) for detecting DSM-5 somatic symptom disorders


KORKMAZ Ş. A., Akalın D., Er B., Duran İ. A.

Current Psychology, cilt.45, sa.22, 2026 (SSCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 45 Sayı: 22
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1007/s12144-026-10269-4
  • Dergi Adı: Current Psychology
  • Derginin Tarandığı İndeksler: Social Sciences Citation Index (SSCI), Scopus, IBZ Online, BIOSIS, Psycinfo, Biomedical Reference Collection: Corporate Edition (EBSCO), Business Source Ultimate (EBSCO), Health Research Premium Collection (ProQuest), Sociology Source Ultimate (EBSCO)
  • Anahtar Kelimeler: DSM-5 criterion B, Psychometric properties, Reliability, Screening, Somatic symptom disorder, SSD-12, Turkish adaptation, Validity
  • Çanakkale Onsekiz Mart Üniversitesi Adresli: Evet

Özet

The Somatic Symptom Disorder–B Criteria Scale (SSD-12) assesses the cognitive, affective, and behavioral responses to somatic symptoms corresponding to Criterion B of somatic symptom disorder (SSD) in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This study aimed to translate and linguistically adapt the SSD-12 into Turkish and evaluate its psychometric properties. This multicenter cross-sectional study included 348 adults: 196 with SSD and 152 without. Participants completed the Turkish SSD-12, Patient Health Questionnaire-15, Hospital Anxiety and Depression Scale, Somatosensory Amplification Scale, Whiteley Index-7, and 12-Item Short Form Health Survey. Structural validity was examined using confirmatory factor analysis. Internal consistency, exploratory follow-up assessment, convergent and incremental validity, and known-groups and sample-specific screening performance were also evaluated. SSD-12 total scores were significantly higher among participants with SSD than among those without SSD (Cohen’s d = 2.38; p < 0.001). The correlated three-factor model showed a better fit than the one-factor model. Internal consistency was excellent for the total scale (Cronbach’s α = 0.963; McDonald’s ω = 0.966). SSD-12 scores correlated significantly with health anxiety, somatic symptom burden, perceived mental and physical health deterioration, anxiety, depression, and somatosensory amplification. After adjustment for somatic symptom burden and clinical covariates, the SSD-12 total score accounted for small but statistically significant increments in the explained variance of mental (ΔR²=0.025) and physical (ΔR²=0.021) health-related quality of life. ROC analysis demonstrated excellent discrimination between participants with and without SSD (AUC = 0.941, 95% CI: 0.916–0.967). A sample-derived threshold of ≥ 14 yielded a sensitivity of 0.934 and specificity of 0.868. The Turkish SSD-12 showed strong internal consistency, with satisfactory evidence for structural, convergent, and incremental validity, as well as clear known-groups discrimination in this sample. These findings support its use as a brief measure of DSM-5 Criterion B symptoms for SSD. A score of ≥ 14 may serve as a preliminary, sample-derived screening threshold, but it should not replace a comprehensive clinical assessment based on the full diagnostic criteria.